OGT Research Conference
Critical Path to treating OGT-XLID
For the first time ever, researchers, clinicians, and patients came together for a dedicated OGT-XLID Conference.
The 2024 OGT-XLID Conference brought together top researchers, clinicians, and professionals from around the globe to explore the latest advancements in the fields of O-GlcNAc Transferase X-Linked Intellectual Disability (also known as OGT-CDG). The event provided a platform to discuss cutting-edge research, potential novel therapies, and innovative technologies shaping the future of OGT-XLID treatment and diagnosis.
The scientific program featured a diverse range of sessions, including:
- In vitro and in cellulo work on variants
- Cell-level Crispr-Cas9 Interventions
- Animal model advancements
- Biomarker for OGT-XLID
- OGT-XLID funding programs
The program also included:
• Meetings with researchers, clinicians and patients.
• A special evening session for networking.
Venue:
The conference was held at the Omni Amelia Island Resort in Florida. It took place the day before the Society for Glycobiology 51st Annual Conference, which also contained an O-GlcNAc session.
Recordings and outcomes are available in the 2024 conference results.
Speakers
Top researchers in the field shared cutting-edge outcomes and developed a joint plan moving forward.
Lance Wells
Associate Director of the CMM, Distinguished Research Professor, GRA Distinguished Investigator Complex Carbohydrate Research Center, University of Georgia
Daan van Aalten
Professor Department of Molecular Biology and Genetics - Cellular Health, Intervention, and Nutrition
Jerry Hart
Professor and GRA Eminent Scholar Member of the Complex Carbohydrate Research Center, University of Georgia
Stephanie Olivier-Van Stichelen
Assistant professor in Biochemistry and OBGYN Medical College of Wisconsin
Andy Edmondson
MD, Attending Physician, Metabolic Disease Program and the Division of Human Genetics at Children’s Hospital of Philadelphia
Hud Freeze
Director Sanford Children’s Health Research Center
Natasha Zachara
Associate Professor of Biological Chemistry Johns Hopkins School of Medicine Faculty
Liujiang Song
Director for Pre-Clinic Department, M34, Inc.
Sandra Retzky
Director, Office of Orphan Products Development, FDA
Frequently Asked Questions
The time for the conference is Saturday, November 9, 2024, 1-5PM ET.
Conference Room Talbot
Feel free to stay in Omni Omelia Island, there are other, more budget-friendly options on the island.
We’re working on a child-care solution with the hotel. Most likely we’ll be able to arrange a child-care.